SCHEMBL29071197

SCHEMBL29071197

CC(C)C(NC(=O)CCOCCN1C(=O)C=CC1=O)C(=O)NC(CCCNC(N)=O)C(=O)Nc1ccc(CCl)cc1

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ FAP Q12884 5/20 0.40
▸ FURIN P09958 5/20 0.37
▸ MAP1LC3B Q9GZQ8 2/20 0.36
▸ HTT P42858 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ NPY1R P25929 1/20 0.33
▸ NPY2R P49146 1/20 0.33
▸ NPY4R P50391 1/20 0.33
▸ NPY5R Q15761 1/20 0.33
▸ CHRNA1 P02708 1/20 0.32
▸ CHRNG P07510 1/20 0.32
▸ CHRNB1 P11230 1/20 0.32
▸ CHRND Q07001 1/20 0.32
▸ LMNA P02545 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SIRT5 Q9NXA8 1/20 0.32
▸ C3AR1 Q16581 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29071195 1.00 FAP (0.40) FAPFURINMAP1LC3BHTTSMN1; SMN2
SCHEMBL24476140 1.00 FAP (0.40) FAPFURINMAP1LC3BHTTSMN1; SMN2
SCHEMBL22432743 0.99 FAP (0.40) FAPFURINMAP1LC3BHTTSMN1; SMN2
SCHEMBL22128022 0.94 FAP (0.40) FAPFURINMAP1LC3BHTTSMN1; SMN2
SCHEMBL22128021 0.94 FAP (0.40) FAPFURINMAP1LC3BHTTSMN1; SMN2
SCHEMBL24476142 0.94 FAP (0.40) FAPFURINMAP1LC3BHTTSMN1; SMN2
SCHEMBL32667737 0.94 FAP (0.40) FAPFURINMAP1LC3BHTTSMN1; SMN2
SCHEMBL21570074 0.94 FAP (0.39) FAPFURINMAP1LC3BHTTNPY1R
SCHEMBL23943282 0.93 FAP (0.40) FAPFURINMAP1LC3BHTTSMN1; SMN2
SCHEMBL24916473 0.93 FURIN (0.42) FAPFURINMAP1LC3BHTTSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116761635-A BCL-XL inhibitor antibody drug conjugates and methods of use thereof 诺华股份有限公司 2023-09-15 — — CN disclosed
Send feedback